Differential TGF-β Signaling in Glial Subsets Underlies IL-6–Mediated Epileptogenesis in Mice

TGF-β1 is a master cytokine in immune regulation, orchestrating both pro- and anti-inflammatory reactions. Recent studies show that whereas TGF-β1 induces a quiescent microglia phenotype, it plays a pathogenic role in the neurovascular unit and triggers neuronal hyperexcitability and epileptogenesis. In this study, we show that, in primary glial cultures, TGF-β signaling induces rapid upregulation of the cytokine IL-6 in astrocytes, but not in microglia, via enhanced expression, phosphorylation, and nuclear translocation of SMAD2/3. Electrophysiological recordings show that administration of IL-6 increases cortical excitability, culminating in epileptiform discharges in vitro and spontaneous seizures in C57BL/6 mice. Intracellular recordings from layer V pyramidal cells in neocortical slices obtained from IL-6–treated mice show that during epileptogenesis, the cells respond to repetitive orthodromic activation with prolonged after-depolarization with no apparent changes in intrinsic membrane properties. Notably, TGF-β1–induced IL-6 upregulation occurs in brains of FVB/N but not in brains of C57BL/6 mice. Overall, our data suggest that TGF-β signaling in the brain can cause astrocyte activation whereby IL-6 upregulation results in dysregulation of astrocyte–neuronal interactions and neuronal hyperexcitability. Whereas IL-6 is epileptogenic in C57BL/6 mice, its upregulation by TGF-β1 is more profound in FVB/N mice characterized as a relatively more susceptible strain to seizure-induced cell death.

[1]  A. Vezzani,et al.  Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability , 2015, Neuropharmacology.

[2]  J. Huguenard,et al.  Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood–brain barrier dysfunction , 2015, Neurobiology of Disease.

[3]  U. Heinemann,et al.  Losartan prevents acquired epilepsy via TGF‐β signaling suppression , 2014, Annals of neurology.

[4]  A. M. White,et al.  The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy , 2014, Neurobiology of Disease.

[5]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[6]  P. Carlen Curious and contradictory roles of glial connexins and pannexins in epilepsy , 2012, Brain Research.

[7]  D. Prince,et al.  Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma , 2012, Neurobiology of Disease.

[8]  Alon Friedman,et al.  Overview and introduction: The blood–brain barrier in health and disease , 2012, Epilepsia.

[9]  A. Vezzani,et al.  Long‐lasting pro‐ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology , 2012, Epilepsia.

[10]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[11]  C. Steinhäuser,et al.  Epilepsy: Crucial role for astrocytes , 2012, Glia.

[12]  Christian Steinhäuser,et al.  Astrocyte dysfunction in temporal lobe epilepsy: K+ channels and gap junction coupling , 2012, Glia.

[13]  U. Heinemann,et al.  Blood‐brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy , 2012, Glia.

[14]  Steffen Jung,et al.  TGF‐β signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment , 2012, Glia.

[15]  K. Miyazono,et al.  Genome-wide mechanisms of Smad binding , 2012, Oncogene.

[16]  K. Schughart,et al.  Generation and characterization of pilocarpine-sensitive C57BL/6 mice as a model of temporal lobe epilepsy , 2012, Behavioural Brain Research.

[17]  P. Schauwecker Strain differences in seizure-induced cell death following pilocarpine-induced status epilepticus , 2012, Neurobiology of Disease.

[18]  David A. Orlando,et al.  Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-β Signaling , 2011, Cell.

[19]  G. Haegeman,et al.  Interleukin-6, a mental cytokine , 2011, Brain Research Reviews.

[20]  U. Heinemann,et al.  Blood-Brain Barrier Dysfunction in Epileptogenesis of the Temporal Lobe , 2011, Epilepsy research and treatment.

[21]  S. Rivest,et al.  CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[22]  T. Wyss-Coray,et al.  Angiotensin II sustains brain inflammation in mice via TGF-beta. , 2010, The Journal of clinical investigation.

[23]  Alon Friedman,et al.  Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury , 2010, Nature Reviews Neurology.

[24]  U. Heinemann,et al.  Astrocytic Dysfunction in Epileptogenesis: Consequence of Altered Potassium and Glutamate Homeostasis? , 2009, The Journal of Neuroscience.

[25]  M. Shapira,et al.  Transcriptome Profiling Reveals TGF-β Signaling Involvement in Epileptogenesis , 2009, The Journal of Neuroscience.

[26]  H. Beck,et al.  Transcriptional Upregulation of Cav3.2 Mediates Epileptogenesis in the Pilocarpine Model of Epilepsy , 2008, The Journal of Neuroscience.

[27]  M. Gutnick,et al.  Endogenous polyamines regulate cortical neuronal excitability by blocking voltage-gated Na+ channels , 2008, Proceedings of the National Academy of Sciences.

[28]  Xiaoming Hu,et al.  Potent Anti-Inflammatory and Neuroprotective Effects of TGF-β1 Are Mediated through the Inhibition of ERK and p47phox-Ser345 Phosphorylation and Translocation in Microglia1 , 2008, The Journal of Immunology.

[29]  Jun Tan,et al.  Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology , 2008, Nature Medicine.

[30]  I. Shelef,et al.  Blood–brain barrier disruption in post-traumatic epilepsy , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[31]  S. Gambhir,et al.  Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. , 2007, The Journal of clinical investigation.

[32]  T. Doetschman,et al.  Endogenous Transforming Growth Factor β1 Suppresses Inflammation and Promotes Survival in Adult CNS , 2007, The Journal of Neuroscience.

[33]  I. M. Vertkin,et al.  Risk Factors , 2007 .

[34]  J. P. Dreier,et al.  Blood–brain barrier disruption results in delayed functional and structural alterations in the rat neocortex , 2007, Neurobiology of Disease.

[35]  Alon Friedman,et al.  TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. , 2007, Brain : a journal of neurology.

[36]  Tony Wyss-Coray,et al.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration , 2006, Proceedings of the National Academy of Sciences.

[37]  L. Mucke,et al.  Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. , 2006, The Journal of clinical investigation.

[38]  O. Steward,et al.  Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains , 2006, The European journal of neuroscience.

[39]  G. Smith,et al.  Genetic background regulates semaphorin gene expression and epileptogenesis in mouse brain after kainic acid status epilepticus , 2005, Neuroscience.

[40]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[41]  Eva Syková,et al.  Voltage‐dependent potassium currents in hypertrophied rat astrocytes after a cortical stab wound , 2004, Glia.

[42]  Jens P Dreier,et al.  Lasting Blood-Brain Barrier Disruption Induces Epileptic Focus in the Rat Somatosensory Cortex , 2004, The Journal of Neuroscience.

[43]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[44]  R. Dingledine,et al.  Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model , 2003, Experimental Neurology.

[45]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-β in vitro and in situ , 2003, Nature Medicine.

[46]  C. Culmsee,et al.  Transforming Growth Factor-β1 Increases Bad Phosphorylation and Protects Neurons Against Damage , 2002, The Journal of Neuroscience.

[47]  D. Janigro Blood–brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms , 1999, Epilepsy Research.

[48]  M S Grady,et al.  Impaired K+ Homeostasis and Altered Electrophysiological Properties of Post-Traumatic Hippocampal Glia , 1999, The Journal of Neuroscience.

[49]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[50]  L. Mucke,et al.  Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice , 1997, Journal of Neuroimmunology.

[51]  O. Steward,et al.  Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Tallie Z. Baram,et al.  The role of inflammation in epilepsy , 2011, Nature Reviews Neurology.

[53]  T. Pedley,et al.  Epilepsy : a comprehensive textbook , 2008 .

[54]  George Samandouras Introduction to Epilepsy , 2005 .